Kemper Corporation 5.875%... (KMPB)
NYSE: KMPB
· Real-Time Price · USD
23.15
-0.10 (-0.43%)
At close: Jun 04, 2025, 3:58 PM
23.18
0.12%
After-hours: Jun 04, 2025, 04:00 PM EDT
Kemper 5.875% Fixed Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Life and Health Insurance Revenue | 387.6M | 835M | 839.1M | 848.1M | n/a | 792.5M | n/a | n/a | n/a | n/a |
| Life and Health Insurance Revenue Growth | -53.58% | -0.49% | -1.06% | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a |
| Other Segments Revenue | n/a | 640.5M | 704M | 726M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Segments Revenue Growth | -100.00% | -9.02% | -3.03% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Preferred Property & Casualty Insurance Revenue | 509.3M | 4.18B | 4.08B | 3.45B | n/a | n/a | n/a | n/a | n/a | n/a |
| Preferred Property & Casualty Insurance Revenue Growth | -87.83% | +2.63% | +18.11% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Specialty Property & Casualty Insurance Revenue | 3.63B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Specialty Property & Casualty Insurance Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 1.12B | -1.09B | 244.3M | 240.7M | 257.3M | 258.4M | 265.7M | 269M | 184.7M | 301.4M | 307.9M | 305M | 307.9M | 310.6M | 313.5M | 283.2M | 346.5M | 275.1M | 270.5M | 269.6M | 175M | 253.6M | 261.6M | 232.7M | 204.9M | 294.1M | 169.4M | 158.4M | 114.9M | 161.1M | 163.5M | 158M | 158.5M | 161.7M | 167.8M | 159.3M | 171.8M | 161.1M | 162.1M | 144.9M |
| Selling, General, and Administrative Revenue Growth | -100.00% | -202.55% | -545.44% | +1.50% | -6.45% | -0.43% | -2.75% | -1.23% | +45.64% | -38.72% | -2.11% | +0.95% | -0.94% | -0.87% | -0.93% | +10.70% | -18.27% | +25.95% | +1.70% | +0.33% | +54.06% | -30.99% | -3.06% | +12.42% | +13.57% | -30.33% | +73.61% | +6.94% | +37.86% | -28.68% | -1.47% | +3.48% | -0.32% | -1.98% | -3.64% | +5.34% | -7.28% | +6.64% | -0.62% | +11.87% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |